Vice President, Global Innovation Policy, and Director, Center for Life Sciences Innovation

Information Technology and Innovation Foundation

Stephen Ezell is vice president for global innovation policy at the Information Technology and Innovation Foundation (ITIF) and director of ITIF’s Center for Life Sciences Innovation. He also leads the Global Trade and Innovation Policy Alliance. His areas of expertise include science and technology policy, international competitiveness, trade, and manufacturing.

Ezell is the coauthor of Innovating in a Service-Driven Economy: Insights, Application, and Practice (Palgrave Macmillan, 2015) and Innovation Economics: The Race for Global Advantage (Yale, 2012).

Ezell came to ITIF from Peer Insight, an innovation research and consulting firm he cofounded in 2003 to study the practice of innovation in service industries. At Peer Insight, Ezell led the Global Service Innovation Consortium, published multiple research papers on service innovation, and researched national service innovation policies being implemented by governments worldwide.

Prior to forming Peer Insight, Ezell worked in the New Service Development group at the NASDAQ Stock Market, where he spearheaded the creation of the NASDAQ Market Intelligence Desk and the NASDAQ Corporate Services Network, services for NASDAQ-listed corporations. Previously, Ezell cofounded two successful innovation ventures, the high-tech services firm Brivo Systems and Lynx Capital, a boutique investment bank.

Ezell holds a B.S. from the School of Foreign Service at Georgetown University, with an honors certificate from Georgetown’s Landegger International Business Diplomacy program.

If you have any questions, please contact our Operations Coordinator

Nellie Valentine at nelle.valentine@auscelerate.org

Please note that by registering for this event, you consent to being added to the WA Life Sciences Innovation Hub and US Consulate Perth mailing lists. Please let us know if you would like to opt out.

Contact the host of WA Spotlight on Global Biopharma: Innovation, Competition and Geopolitics

There were 0 errors found in the information you submitted: